HK1000913A1 - Use of indolone derivatives for the preparation of medicaments for the treatment of parkinsons disease - Google Patents

Use of indolone derivatives for the preparation of medicaments for the treatment of parkinsons disease Download PDF

Info

Publication number
HK1000913A1
HK1000913A1 HK97102520A HK97102520A HK1000913A1 HK 1000913 A1 HK1000913 A1 HK 1000913A1 HK 97102520 A HK97102520 A HK 97102520A HK 97102520 A HK97102520 A HK 97102520A HK 1000913 A1 HK1000913 A1 HK 1000913A1
Authority
HK
Hong Kong
Prior art keywords
compound
treatment
activity
test
preparation
Prior art date
Application number
HK97102520A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1000913B (en
Inventor
Andrew Arlwydd Owen David
Original Assignee
Smith Kline & French Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10617727&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1000913(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smith Kline & French Laboratories Limited filed Critical Smith Kline & French Laboratories Limited
Publication of HK1000913A1 publication Critical patent/HK1000913A1/en
Publication of HK1000913B publication Critical patent/HK1000913B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HK97102520.9A 1987-05-21 1997-12-19 Use of indolone derivatives for the preparation of medicaments for the treatment of parkinsons disease HK1000913B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8712073 1987-05-21
GB878712073A GB8712073D0 (en) 1987-05-21 1987-05-21 Medicament

Publications (2)

Publication Number Publication Date
HK1000913A1 true HK1000913A1 (en) 1998-05-08
HK1000913B HK1000913B (en) 1998-05-08

Family

ID=

Also Published As

Publication number Publication date
AU599792B2 (en) 1990-07-26
LU90098I2 (fr) 1997-09-25
GB8712073D0 (en) 1987-06-24
US4824860A (en) 1989-04-25
JPS63303966A (ja) 1988-12-12
NL970006I2 (nl) 1997-10-01
EP0299602A3 (en) 1990-06-06
ZA883602B (en) 1989-04-26
HU201871B (en) 1991-01-28
DE3876877T2 (de) 1993-04-29
HUT47217A (en) 1989-02-28
EP0299602A2 (en) 1989-01-18
PT87542A (pt) 1989-05-31
DK275488A (da) 1988-11-22
EP0299602B1 (en) 1992-12-23
MX9203543A (es) 1992-07-01
IE881469L (en) 1988-11-21
DE3876877D1 (de) 1993-02-04
NZ224709A (en) 1997-02-24
GR3007251T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-07-30
PT87542B (pt) 1992-09-30
US4912126A (en) 1990-03-27
DK275488D0 (da) 1988-05-19
NL970006I1 (nl) 1997-04-01
ES2052717T3 (es) 1994-07-16
JPH062672B2 (ja) 1994-01-12
IE63511B1 (en) 1995-05-03
ATE83659T1 (de) 1993-01-15
DK169609B1 (da) 1994-12-27
AU1644588A (en) 1988-11-24
PH23867A (en) 1989-11-23
CA1305421C (en) 1992-07-21

Similar Documents

Publication Publication Date Title
EP0299602B1 (en) Use of indolone derivatives for the preparation of medicaments for the treatment of parkinsons disease
JP2602253B2 (ja) 神経毒障害の悪影響を減少させるための組成物
US20100144858A1 (en) Treatment of movement disorders with a metabotropic glutamate 4 receptor positive allosteric modulator
Bowyer Phencyclidine inhibition of the rate of development of amygdaloid kindled seizures
BRPI0618918B1 (pt) uso de um primeiro composto e um segundo composto para tratar uma condição de glicose sanguínea
AU2002340971B2 (en) Use of 2-oxo-1-pyrrolidine derivatives for the treatment of dyskinesia and movement disorders
US20020068692A1 (en) Method for the treatment of neurological or neuropsychiatric disorders
WO1993012775A1 (en) Pharmaceutical composition and process for the preparation thereof
IE843149L (en) Synergistic pharmaceutical compositions
Mackay et al. Pharmacotherapeutic trials in tardive dyskinesia
OA12063A (en) Synergistic combinations of an UK1 receptor antag onist and a GABA structural analog.
JPS61286326A (ja) パ−キンソン病治療薬
HK1000913B (en) Use of indolone derivatives for the preparation of medicaments for the treatment of parkinsons disease
Weiner et al. Dopaminergic antagonism of L‐5‐hydroxytryptophan‐induced myoclonic jumping behavior
Cannon et al. Future directions in dopaminergic nervous system and dopaminergic agonists
US6552087B1 (en) Therapeutic agent comprising (+)-sibutramine
Kuno Differential therapeutic effects of dopamine D1 and D2 agonists in MPTP-induced parkinsonian monkeys: clinical implications
Sandyk et al. L-tryptophan supplementation in Parkinson's disease
US3360434A (en) Method for reducing blood pressure with phenylalanine derivatives
US4645770A (en) Agent for treating Parkinson's disease or Parkinsonism
JPH09500375A (ja) パーキンソン病の治療を目的とする医薬品の製造のためのエファロキサンおよびその誘導体の使用
US9006274B2 (en) Thiazole derivatives for treating dyskinesias caused by a chemical treatment
Smith et al. The role of monoamines for the central effects of baclofen on behavior of rats
EP1303277B1 (fr) Composition pharmaceutique a base de cocaethylene et son utilisation pour le traitement de la dependance aux substances psychoactives
EP1180058A1 (en) Combinations of gaba analogs and tricyclic compounds to treat depression

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20080518